We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Aruna Biomedical Announces Agreement to Commercialize the Human Embryonic Stem Cells Products

News   Jan 31, 2007

 
Aruna Biomedical Announces Agreement to Commercialize the Human Embryonic Stem Cells Products
 
 
 

RELATED ARTICLES

Omega-3 Fatty Acids’ Health Benefit Linked to Stem Cell Control

News

For years, researchers have known that defects in the primary cilium are linked with obesity and insulin resistance. Now, researchers at the Stanford University School of Medicine have discovered that the strange little cellular appendage is sensing omega-3 fatty acids in the diet, and that this signal is directly affecting how stem cells in fat tissue divide and turn into fat cells.

READ MORE

Coaxing Stem Cells Into Custom Shapes Could Be Route to Personalized Organs

News

Researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.

READ MORE

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive

News

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE